Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS)

Chemico-Biological Interactions

Volumn 192, Issue 1-2, 2011, Pages 136-141

  Messeguer, Angel ^a  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

3 (N Phenylamino) propane 1,2 diol derivatives; Adducts with thiol reagents; Anilides; Deodorisation; Iminoquinone intermediates; Rapeseed oil; Toxic Oil Syndrome

Indexed keywords

ACETYLCYSTEINE; AMIDE; ANILINE DERIVATIVE; GLUTATHIONE; OLEIC ACID; RAPESEED OIL; RECOMBINANT ENZYME; TRIACYLGLYCEROL LIPASE;

BIOTRANSFORMATION; CHEMICAL STRUCTURE; CONFERENCE PAPER; DEODORIZATION; HUMAN; HYDROLYSIS; IN VITRO STUDY; LIVER MICROSOME; PROTEIN STABILITY; TOXIC OIL SYNDROME;

ANILINE COMPOUNDS; BIOTRANSFORMATION; HUMANS; LIPASE; PLANT OILS;

BRASSICA NAPUS; RATTUS;

EID: 79958022088     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.10.006     Document Type: Conference Paper

References (28)

1. J.M. Tabuenca Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline Lancet 2 1981 567
2. W.N. Aldridge The Toxic Oil Syndrome (TOS 1981): from the disease towards a toxicological understanding of its chemical etiology and mechanism Toxicol. Lett. 64-65 1992 59 70 (Pubitemid 23018739)
3. A. Vázquez Roncero, C. Janer del Valle, R. Maestro Duran, and E. Graciano Constante New aniline derivatives in cooking oils associated with toxic oil síndrome Lancet 2 1983 1024 1025 (Pubitemid 14225074)
4. M. Posada de la Paz, R.M. PhileN, and I. Abaitua Toxic Oil Syndrome: the perspective after twenty years Epidemiol. Rev. 23 2001 231 247 (Pubitemid 34074111)
5. M.G. Ladona, J. Bujons, A. Messeguer, C. Ampurdanés, A. Morató, and J. Corbella Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to Toxic Oil Syndrome, in C57BL/6 and A/J mice Chem. Res. Toxicol. 12 1999 1127 1137 (Pubitemid 30013521)
6. J. Bujons, M.G. Ladona, A. Messeguer, A. Morató, and C. Ampurdanés Metabolism of (R)- and (S)-3(phenylamino)propane-1,2-diol in C57BL/6- and A/J-strain mice. Identification of new metabolites with toxicological significance to the Toxic Oil Syndrome Chem. Res. Toxicol. 14 2001 1097 1106 (Pubitemid 32800166)
7. R.H. Hill, H.H. Schurz, M. Posada de la Paz, I. Abaitua-Borda, R.M. Philen, E.M. Kilbourne, S.L. Head, S.L. Bailey, W.J. Driskell, J.R. Barr, and L.L. Needham Possible etiologic agents for Toxic Oil Syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol Arch. Environ. Contam. Toxicol. 28 1995 259 264
8. M.V. Ruiz-Méndez, M. Posada de la Paz, J. Abian, R.E. Calaf, B. Blount, N. Castro-Molero, R. Philen, and E. Gelpí Storage time and deodorisation temperature influence the formation of aniline-derived compounds in denatured rapeseed oils Food Chem. Toxicol. 39 2001 91 96 (Pubitemid 32226367)
9. A. Morató, A. Manich, N. Reig, J. Escabrós, Y. Castaño, J. Abian, and A. Messeguer On the formation and chemical interconversion of 3-N-Phenylamino-1,2-propanediol derivatives in a Toxic Oil Syndrome model oil Chem. Res. Toxicol. 18 2005 665 674 (Pubitemid 40563280)
10. N. Reig, R.E. Calaf, Y. Castaño, R. Prieto, A. Messeguer, A. Morató, J. Escabrós, E. Gelpí, and J. Abian Characterization of new aniline derivatives of fatty acids and triglycerides in samples of laboratory refined rapeseed oil denatured with aniline J. Mass Spectrom. 42 2007 527 541 (Pubitemid 46649088)
11. J. Escabrós, R. Crehuet, and A. Messeguer Studies on the Toxic Oil Syndrome: proposal of a mechanism for the thermal conversion of 3-N-phenylamino-1,2-propanediol esters into anilides under deodorisation conditions Tetrahedron 65 2009 418 426
12. A. Morató, A. Martínez-Cabot, J. Escabrós, J. Bujons, and A. Messeguer Studies on Toxic Oil Syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase Chem. Res. Toxicol. 17 2004 889 895 (Pubitemid 38955347)
13. I. Abaitua-Borda, and M. Posada de la Paz Clinical findings Toxic Oil Syndrome: Current Knowledge and Future Perspectives, WHO Reg. Eur. Ser. No 42 World Health Organisation Regional office for Europe, Copenhagen, Denmark 1992 26 36
14. A. Martínez-Cabot, A. Morató, J.N.M. Commandeur, N.P.E. Vermeulen, and A. Messeguer In vitro bioactivation of 3-N-Phenylamino-1,2- propanediol by human and rat liver microsomes and recombinant P450 isoforms. Implications for Toxic Oil Syndrome Chem. Res. Toxicol. 20 2007 1218 1224 (Pubitemid 47373003)
15. H. Raunio, J. Hakkola, J. Hukkanen, A. Lassila, K. Paivarinta, O. Pelkonen, S. Anttila, R. Piipari, A. Boobis, and R.J. Edwards Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue Exp. Toxicol. Pathol. 51 1999 412 417 (Pubitemid 29334377)
16. J. Hukkanen, O. Pelkonen, J. Hakkola, and H. Raunio Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung Crit. Rev. Toxicol. 32 2002 391 411 (Pubitemid 35191358)
17. J.V. Castell, M.T. Donato, and M.J. Gomez-Lechon Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach Exp. Toxicol. Pathol. 57 2005 89 204
18. L. Silvestri, L. Sonzogni, A. De Silvestri, C. Gritti, L. Foti, C. Zavaglia, M. Leveri, A. Cividini, M.U. Mondelli, E. Civardi, and E.M. Silini CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer Int. J. Cancer 104 2003 310 327
19. K. Nagata, and Y. Yamazoe Genetic polymorphism Drug Metabol. Pharmacokin. 17 2002 167 189
20. A. Martínez-Cabot, A. Morató, and A. Messeguer Synthesis and stability studies of the glutathione and N-acetylcysteine adducts of an quinoneimine reactive intermediate generated in the biotransformation of 3-(N-phenylamino)propane-1,2-diol: implications for toxic oil syndrome Chem. Res. Toxicol. 18 2005 1721 1728 (Pubitemid 43257754)
21. W. Li, J. Heinze, and W. Haehnel Site-specific binding of quinone to proteins through thiol addition and addition-elimination reactions J. Am. Chem Soc. 127 2005 6140 6141 (Pubitemid 40637190)
22. C.K.M. Klos, C. Kramer, and W. Dekant p-Aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates Toxicol. Appl. Pharmacol. 115 1992 98 106
23. L.M. Fowler, J.R. Foster, and E.A. Lock Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors Arch. Toxicol. 68 1994 15 23 (Pubitemid 24041660)
24. J. Varga, S.A. Jimenez, and J. Uitto l-Tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis J. Invest. Dermatol. 100 1993 457 465
25. R.M. Silver, A. Ludwika, M. Hampton, T. Ohba, S.A. Bingel, T. Smith, R.A. Harley, J. Maize, and M.P. Heyes A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (l-tryptophan) J. Clin. Invest. 93 1994 1473 1480
26. A.N. Mayeno, L.M. Benson, S. Naylor, M. Colberg-Beers, J.T. Puchalski, and G.J. Gleich Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome Chem. Res. Toxicol. 8 1995 911 916
27. A. Martínez-Cabot, and A. Messeguer Generation of quinoneimine Intermediates in the Bioactivation of 3-(N-Phenylamino)alanine (PAA) by Human Liver Microsomes. A potential link between the Eosinophilia-Myalgia Syndrome and the Toxic Oil Syndrome Chem. Res. Toxicol. 20 2007 1556 1662
28. B. Terracini Toxic Oil Syndrome. Ten Years of Progress 2004 World Health Organisation, Regional Office for Europe